Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
150%(3 trials)
Terminated
2(40%)

Phase Distribution

Ph phase_4
2
40%
Ph phase_3
3
60%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
3(60.0%)
Phase 4Post-market surveillance
2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Terminated(2)

Detailed Status

Terminated2
Completed2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 33 (60.0%)
Phase 42 (40.0%)

Trials by Status

terminated240%
not_yet_recruiting120%
completed240%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingphase_3

Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic Dermatitis

NCT07162896
terminatedphase_4

Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis

NCT05200403
completedphase_3

A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis

NCT04040192
completedphase_4

Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis

NCT03868098
terminatedphase_3

A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis

NCT04498403

Clinical Trials (5)

Showing 5 of 5 trials
NCT07162896Phase 3

Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic Dermatitis

Not Yet Recruiting
NCT05200403Phase 4

Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis

Terminated
NCT04040192Phase 3

A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis

Completed
NCT03868098Phase 4

Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis

Completed
NCT04498403Phase 3

A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis

Terminated

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5